Compugroup Medspadr 1 Stock Three Year Return
| COPA Stock | EUR 21.20 0.40 1.85% |
COMPUGROUP MEDSPADR 1 fundamentals help investors to digest information that contributes to COMPUGROUP MEDSPADR's financial success or failures. It also enables traders to predict the movement of COMPUGROUP Stock. The fundamental analysis module provides a way to measure COMPUGROUP MEDSPADR's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to COMPUGROUP MEDSPADR stock.
COMPUGROUP |
COMPUGROUP MEDSPADR 1 Company Three Year Return Analysis
COMPUGROUP MEDSPADR's Tree Year Return shows the total annualized return generated from holding a fund or ETFs for the last three years. The return measure includes capital appreciation, losses, dividends paid, and all capital gains distributions. This return indicator is considered by many investors to be solid measures of fund mid-term performance.
More About Three Year Return | All Equity Analysis
Three Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Three Year Fund Return indicator can give a sense of overall fund mid-term potential, it is recommended to compare fund performances against other similar funds, ETFs, or market benchmarks for the same 3 year interval.
| Competition |
Based on the latest financial disclosure, COMPUGROUP MEDSPADR 1 has a Three Year Return of 0.0%. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Health Information Services (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
Did you try this?
Run Portfolio Volatility Now
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk |
| All Next | Launch Module |
COMPUGROUP Fundamentals
| Return On Equity | 0.11 | |||
| Return On Asset | 0.031 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.08 % | |||
| Shares Outstanding | 52.23 M | |||
| Price To Earning | 53.50 X | |||
| Revenue | 1.13 B | |||
| Gross Profit | 373.55 M | |||
| EBITDA | 149.63 M | |||
| Net Income | 72.32 M | |||
| Cash And Equivalents | 91.45 M | |||
| Cash Per Share | 1.73 X | |||
| Total Debt | 685.04 M | |||
| Debt To Equity | 1.19 % | |||
| Current Ratio | 0.91 X | |||
| Book Value Per Share | 12.98 X | |||
| Cash Flow From Operations | 165.54 M | |||
| Earnings Per Share | 1.37 X | |||
| Number Of Employees | 8.83 K | |||
| Beta | 1.02 | |||
| Market Capitalization | 2.72 B | |||
| Z Score | 1.8 | |||
| Annual Yield | 0.01 % | |||
| Last Dividend Paid | 0.5 |
About COMPUGROUP MEDSPADR Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze COMPUGROUP MEDSPADR 1's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of COMPUGROUP MEDSPADR using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of COMPUGROUP MEDSPADR 1 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in COMPUGROUP Stock
COMPUGROUP MEDSPADR financial ratios help investors to determine whether COMPUGROUP Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in COMPUGROUP with respect to the benefits of owning COMPUGROUP MEDSPADR security.